Computational Medicine and Drug Discovery Software Market - Forecast(2021 - 2026)

Report Code: HCR 0016 Report Format: PDF + Excel (Delivery in 48 Hrs)

Computational Medicine and Drug Discovery Software Market Overview

Computational Medicine and Drug Discovery Software Market size is estimated at $700.4 million in 2020, projected to grow at a CAGR of 3.5% during the forecast period 2021-2026. Computational Medicine and Drug Discovery Software is a new field dedicated to learning more about the processes, diagnosis, and treatment of human disease. The process of discovering novel medicines is known as drug discovery. Computational medicine also aids in the detection of genetic flaws and as a result, aids in the prediction of disease causation. Protein-protein interactions as well as protein-ligand interactions are realized using computational medicine and drug discovery software, making it easier to catch the drug target. Increasing government and private sector R&D investments, rising trends in personalized medication consumption, and advancements in information technology, as well as the advent of fast and dependable computing technologies is set to drive its Computational Medicine and Drug Discovery Software industry.

Report Coverage

The report: “Computational Medicine and Drug Discovery Software Market Forecast (2021-2026)”, by Industry ARC, covers an in-depth analysis of the following segments of the Computational Medicine and Drug Discovery Software Market.
By Tools: Software and Database.
By Application: Computational Physiological Medicine, Predictive Analysis of Drug Targets, Cellular Simulation, Simulation Software, Drug Discovery & Development, Medical Imaging, Disease Modeling, Genomics, Proteomics, Molecular Biology, Gene Expression Analysis and Others.
By Geography: North America (U.S, Canada and Mexico), Europe (Germany, UK, France, Italy, Spain, Russia and Rest of Europe), Asia Pacific (China, Japan India, South Korea, Australia & New Zealand, and Rest of Asia Pacific), South America (Brazil, Argentina and Rest of South America) and RoW (Middle East and Africa).

Key Takeaways

  • Computational Medicine and Drug Discovery Software market growth is being driven by technological advances, increasing research activities on drug designing and development government and many different private companies that are increasing investment in Research and Development.
  • Geographically, North America Computational Medicine and Drug Discovery Software Market held the largest revenue share of 38% in 2020 owing to the rising funding by the government and private players in R&D and emergence of startups relating to this field and increasing partnerships with pharmaceutical companies. The scope of the market for various regions will be provided in the final report.
  • The Computational Medicine and Drug Discovery Software Industry is expanding owing to rising perception of the product’s benefits in various applications and consumer preferences are expected to shift as quality levels increase.
  • The developing healthcare facilities and the greater means of people to spend on better quality software also have contributed to approval of Computational Medicine and Drug Discovery Software in the medicine.

Computational Medicine and Drug Discovery Software Market: Market Share (%) by Region, 2020
Computational Medicine and Drug Discovery Software Market
For More Details on This Report - Request for Sample

Computational Medicine and Drug Discovery Software Market Segment Analysis – By Tools:

Based on Tools, Software Segment accounted for the largest revenue market share in 2020 and is also anticipated to grow with the fastest CAGR as it makes use of cutting-edge technologies to speed up drug development testing and market launch. It helps and promises to increase image quality and assist doctors in predicting ailments, which would otherwise take a long time to complete. Database segment is anticipated to grow with the second fastest CAGR of 0.8% in the forecast period 2021-2026. Database helps in storing structured information electronically. By building new products that run on cloud and mobile platforms, database suppliers have a huge opportunity to penetrate these high-potential sectors. The usage of cloud data access has grown in popularity, owing to the involvement of a variety of stakeholders, as well as multiple functional departments within enterprises, in the research process, where each can access and use the data as needed. For instance, the FDA Adverse Event Reporting System (FAERS) database contains data on adverse event and drug error reports that have been submitted to the agency. The database is intended to aid the FDA's post-market medication and therapeutic biologic product safety surveillance program which is fuelling the market's growth.

Computational Medicine and Drug Discovery Software Market Segment Analysis – By Application:

Based on Application, Drug Discovery & Development accounted for the largest revenue market share in 2020 and is also anticipated to grow with the fastest CAGR for the period 2021-2026. The drug development process leads to the discovery of new drugs. Chemical libraries, such as tiny compounds, natural products, or plant extracts, are investigated using traditional pharmacology. The sequencing of human DNA has paved way for reverse pharmacology that can be used in testing to find cures for existing ailments. Drug development is aided by disease processes, molecular compound assays, existing medicines with unexpected side effects, and new technologies. Screening hits, medicinal chemistry, and optimization of hits to lessen potential drug side effects by boosting affinity and selectivity are all part of drug discovery and development. Drug development is not only a time-consuming and labor-intensive procedure, but it is also fraught with danger driving the segment growth. Predictive Analysis of Drug Targets is projected to witness the second fastest CAGR of 4.0% during the forecast period 2021-2026. Prediction of drug-target interaction becomes an important method in the drug repurposing market. The availability of heterogeneous biological data on established drug-target interactions allowed many researchers to develop different computational methods for deciphering unknown interactions between drug targets driving the segment growth.

Computational Medicine and Drug Discovery Software Market Segment Analysis – By Geography:

Based on Geography, North America Computational Medicine and Drug Discovery Software Market accounted for the 38% revenue share in 2020 owing to personalised medicine demand and their utility in drug development, and increased expenditure in research and development. Increasing number of diseases in the U.S. led to the demand for research in drug discovery. Fields of bioinformatics and personalized medicine development have grown rapidly owing to this increase in research. This in turn is also driving the market. In the U.S., the number of pharmaceutical companies is more and also their investments in various technologies are also more. There were 2,946 biotech businesses in the U.S as of 2019, as per estimate by Seedscientific. This is contributing to the major share of this region in computational medicine and drug discovery market across the region. Asia-Pacific is predicted to be the fastest growing region during the forecast period 2021- 2026. The region is currently supporting many conceptualized project proposals for carrying out research in the field of Bioinformatics and Computational Medicine. Considering the importance, many projects particular in the areas of cancer, tuberculosis and pulmonary diseases, diabetic & cardiovascular diseases, neurological disorders and methods/ drug development are being supported, drives Computational Medicine and Drug Discovery Software Industry.

Computational Medicine and Drug Discovery Software Market - Drivers

The Growing Advancements in Bioinformatics:

The market for computational medicine and drug discovery software is growing due to the growing trend of consuming personalized medication and the progress of information technology, as well as the introduction of quick and accurate computational platforms. Bioinformatics is the use of computational and analytical tools to acquire and understand biological data. It is critical for data management in modern biology and medicine, resulting in a higher demand for bioinformatics. Software can help people understand the advantages of bioinformatics, which can help with gene expression and drug development by establishing an objective and rational drug attractiveness index. The evolution of Bioinformatics has been a global endeavour, resulting in the creation of computer networks that have permitted easy access to biological data and the development of software applications for simple analysis driving the industry growth.

Computational Medicine and Drug Discovery Software Market - Challenges

Shortage of Skilled Professional: 

There is a significant knowledge gap among specialists on how to use various software tools for drug discovery. Many academic stages lack software tool usage because researchers are not trained in software tools and techniques. Manual interventions and lengthy installation timeframes are undesirable to a wide range of users, particularly those with limited computational abilities. Many researchers in the life sciences and medicine lack proper computational knowledge and may be unable to make manual treatments hampers Computational Medicine and Drug Discovery Software Market’s growth.

Computational Medicine and Drug Discovery Software Market - Landscape:

The Computational Medicine and Drug Discovery Software Market's main strategies include product launches, mergers and acquisitions, joint ventures, and regional expansion. Computational Medicine and Drug Discovery Software Market top 10 companies are Chemical Computing Group, Instem PLC, Crown Biosciences Inc., Roche, Dassault Systemes, Scrodinger LLC, Genedata LLC, Entelos Inc., Nimbus Therapeutics Inc. and Certara LP.

Acquisitions/Product Launches:

  • In April 2020, Crown Bioscience announced the strategic expansion of their PDX collection through new agreements with CoMotion at the university of Washington and Dana-Faber Cancer Institute which will provide providing high needed prostate cancer and lymphoma models respectively.

Related Reports-

Report Code: HCR 0434

Report Code: HCR 0184

For more Lifesciences and Healthcare related reports, please click here
1. Computational Medicine and Drug Discovery Software Market - Overview
    1.1 Definitions and Scope
2. Computational Medicine and Drug Discovery Software Market - Executive Summary
    2.1 Market Revenue, Market Size and Key Trends
    2.2 Key trends by Tools
    2.3 Key trends by Application
    2.4 Key trends by Geography
3. Computational Medicine and Drug Discovery Software Market - Comparative Analysis
    3.1 Service Benchmarking – Key Companies
    3.2 Financial Analysis– Key Companies
    3.3 Market Share Analysis
    3.4 Patent Analysis
    3.5 Pricing Analysis- Average Price
4. Computational Medicine and Drug Discovery Software Market - Startup Companies Scenario Premium
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. Computational Medicine and Drug Discovery Software Market – Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing Business Index
    5.3 Case Studies of Successful Ventures
6. Computational Medicine and Drug Discovery Software Market - Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters Five Force Model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes 
7. Computational Medicine and Drug Discovery Software Market – Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Computational Medicine and Drug Discovery Software Market – By Tools (Market Size –$Million/$Billion)
    8.1 Software
    8.2 Database
9. Computational Medicine and Drug Discovery Software Market – By Application (Market Size –$Million/$Billion)
    9.1 Computational Physiological Medicine
    9.2 Predictive Analysis of Drug Targets
    9.3 Cellular Simulation
    9.4 Simulation Software
    9.5 Drug Discovery & Development
    9.6 Medical Imaging
    9.7 Disease Modeling
    9.8 Genomics
    9.9 Proteomics
    9.10 Molecular Biology
    9.11 Gene Expression Analysis
    9.12 Others
10. Computational Medicine and Drug Discovery Software Market - By Geography (Market Size –$Million/$Billion)
    10.1 North America
        10.1.1 U.S.
        10.1.2 Canada
        10.1.3 Mexico
    10.2 Europe
        10.2.1 U.K.
        10.2.2 Germany
        10.2.3 France
        10.2.4 Italy
        10.2.5 Spain
        10.2.6 Russia
        10.2.7 Rest of Europe
    10.3 Asia-Pacific
        10.3.1 China
        10.3.2 India
        10.3.3 Japan
        10.3.4 South Korea
        10.3.5 Australia & New Zealand
        10.3.6 Rest of Asia-Pacific
    10.4 South America
        10.4.1 Brazil
        10.4.2 Argentina
        10.4.3 Rest of South America
    10.5 Rest of the World
        10.5.1 Middle East
        10.5.2 Africa
11. Computational Medicine and Drug Discovery Software Market - Entropy
12. Computational Medicine and Drug Discovery Software Market – Industry/Segment Competition Landscape   Premium 
    12.1 Market Share Analysis
        12.1.1 Global Market Share – Key Companies
        12.1.2 Market Share by Region – Key companies
        12.1.3 Market Share by Countries – Key Companies
        12.1.4 Best Practices for Companies
13. Computational Medicine and Drug Discovery Software Market – Key Company List by Country Premium Premium
14. Computational Medicine and Drug Discovery Software Market Company Analysis
    14.1 Company 1
    14.2 Company 2
    14.3 Company 3
    14.4 Company 4
    14.5 Company 5
    14.6 Company 6
    14.7 Company 7
    14.8 Company 8
    14.9 Company 9
    14.10 Company 10
"*Financials for private companies would be provided on a best efforts basis”.
List of Tables

Table 1: Computational Medicine And Drug Discovery Software Market Overview 2019-2024
Table 2: Computational Medicine And Drug Discovery Software Market Leader Analysis 2018-2019 (US$)
Table 3: Computational Medicine And Drug Discovery Software Market Product Analysis 2018-2019 (US$)
Table 4: Computational Medicine And Drug Discovery Software Market End User Analysis 2018-2019 (US$)
Table 5: Computational Medicine And Drug Discovery Software Market Patent Analysis 2013-2018* (US$)
Table 6: Computational Medicine And Drug Discovery Software Market Financial Analysis 2018-2019 (US$)
Table 7: Computational Medicine And Drug Discovery Software Market Driver Analysis 2018-2019 (US$)
Table 8: Computational Medicine And Drug Discovery Software Market Challenges Analysis 2018-2019 (US$)
Table 9: Computational Medicine And Drug Discovery Software Market Constraint Analysis 2018-2019 (US$)
Table 10: Computational Medicine And Drug Discovery Software Market Supplier Bargaining Power Analysis 2018-2019 (US$)
Table 11: Computational Medicine And Drug Discovery Software Market Buyer Bargaining Power Analysis 2018-2019 (US$)
Table 12: Computational Medicine And Drug Discovery Software Market Threat of Substitutes Analysis 2018-2019 (US$)
Table 13: Computational Medicine And Drug Discovery Software Market Threat of New Entrants Analysis 2018-2019 (US$)
Table 14: Computational Medicine And Drug Discovery Software Market Degree of Competition Analysis 2018-2019 (US$)
Table 15: Computational Medicine And Drug Discovery Software Market Value Chain Analysis 2018-2019 (US$)
Table 16: Computational Medicine And Drug Discovery Software Market Pricing Analysis 2019-2024 (US$)
Table 17: Computational Medicine And Drug Discovery Software Market Opportunities Analysis 2019-2024 (US$)
Table 18: Computational Medicine And Drug Discovery Software Market Product Life Cycle Analysis 2019-2024 (US$)
Table 19: Computational Medicine And Drug Discovery Software Market Supplier Analysis 2018-2019 (US$)
Table 20: Computational Medicine And Drug Discovery Software Market Distributor Analysis 2018-2019 (US$)
Table 21: Computational Medicine And Drug Discovery Software Market Trend Analysis 2018-2019 (US$)
Table 22: Computational Medicine And Drug Discovery Software Market Size 2018 (US$)
Table 23: Computational Medicine And Drug Discovery Software Market Forecast Analysis 2019-2024 (US$)
Table 24: Computational Medicine And Drug Discovery Software Market Sales Forecast Analysis 2019-2024 (Units)
Table 25: Computational Medicine And Drug Discovery Software Market, Revenue & Volume,By Tools, 2019-2024 ($)
Table 26: Computational Medicine And Drug Discovery Software Market By Tools, Revenue & Volume,By Database, 2019-2024 ($)
Table 27: Computational Medicine And Drug Discovery Software Market By Tools, Revenue & Volume,By Software, 2019-2024 ($)
Table 28: Computational Medicine And Drug Discovery Software Market, Revenue & Volume,By Application, 2019-2024 ($)
Table 29: Computational Medicine And Drug Discovery Software Market By Application, Revenue & Volume,By Computational Physiological Medicine, 2019-2024 ($)
Table 30: Computational Medicine And Drug Discovery Software Market By Application, Revenue & Volume,By Drug Discovery and Development, 2019-2024 ($)
Table 31: Computational Medicine And Drug Discovery Software Market By Application, Revenue & Volume,By Medical Imaging, 2019-2024 ($)
Table 32: Computational Medicine And Drug Discovery Software Market By Application, Revenue & Volume,By Disease Modeling, 2019-2024 ($)
Table 33: Computational Medicine And Drug Discovery Software Market By Application, Revenue & Volume,By Predictive Analysis of Drug Targets, 2019-2024 ($)
Table 34: North America Computational Medicine And Drug Discovery Software Market, Revenue & Volume,By Tools, 2019-2024 ($)
Table 35: North America Computational Medicine And Drug Discovery Software Market, Revenue & Volume,By Application, 2019-2024 ($)
Table 36: South america Computational Medicine And Drug Discovery Software Market, Revenue & Volume,By Tools, 2019-2024 ($)
Table 37: South america Computational Medicine And Drug Discovery Software Market, Revenue & Volume,By Application, 2019-2024 ($)
Table 38: Europe Computational Medicine And Drug Discovery Software Market, Revenue & Volume,By Tools, 2019-2024 ($)
Table 39: Europe Computational Medicine And Drug Discovery Software Market, Revenue & Volume,By Application, 2019-2024 ($)
Table 40: APAC Computational Medicine And Drug Discovery Software Market, Revenue & Volume,By Tools, 2019-2024 ($)
Table 41: APAC Computational Medicine And Drug Discovery Software Market, Revenue & Volume,By Application, 2019-2024 ($)
Table 42: Middle East & Africa Computational Medicine And Drug Discovery Software Market, Revenue & Volume,By Tools, 2019-2024 ($)
Table 43: Middle East & Africa Computational Medicine And Drug Discovery Software Market, Revenue & Volume,By Application, 2019-2024 ($)
Table 44: Russia Computational Medicine And Drug Discovery Software Market, Revenue & Volume,By Tools, 2019-2024 ($)
Table 45: Russia Computational Medicine And Drug Discovery Software Market, Revenue & Volume,By Application, 2019-2024 ($)
Table 46: Israel Computational Medicine And Drug Discovery Software Market, Revenue & Volume,By Tools, 2019-2024 ($)
Table 47: Israel Computational Medicine And Drug Discovery Software Market, Revenue & Volume,By Application, 2019-2024 ($)
Table 48: Top Companies 2018 (US$)Computational Medicine And Drug Discovery Software Market, Revenue & Volume
Table 49: Product Launch 2018-2019Computational Medicine And Drug Discovery Software Market, Revenue & Volume
Table 50: Mergers & Acquistions 2018-2019Computational Medicine And Drug Discovery Software Market, Revenue & Volume


List of Figures

Figure 1: Overview of Computational Medicine And Drug Discovery Software Market 2019-2024
Figure 2: Market Share Analysis for Computational Medicine And Drug Discovery Software Market 2018 (US$)
Figure 3: Product Comparison in Computational Medicine And Drug Discovery Software Market 2018-2019 (US$)
Figure 4: End User Profile for Computational Medicine And Drug Discovery Software Market 2018-2019 (US$)
Figure 5: Patent Application and Grant in Computational Medicine And Drug Discovery Software Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Computational Medicine And Drug Discovery Software Market 2018-2019 (US$)
Figure 7: Market Entry Strategy in Computational Medicine And Drug Discovery Software Market 2018-2019
Figure 8: Ecosystem Analysis in Computational Medicine And Drug Discovery Software Market 2018
Figure 9: Average Selling Price in Computational Medicine And Drug Discovery Software Market 2019-2024
Figure 10: Top Opportunites in Computational Medicine And Drug Discovery Software Market 2018-2019
Figure 11: Market Life Cycle Analysis in Computational Medicine And Drug Discovery Software Market
Figure 12: GlobalBy ToolsComputational Medicine And Drug Discovery Software Market Revenue, 2019-2024 ($)
Figure 13: GlobalBy ApplicationComputational Medicine And Drug Discovery Software Market Revenue, 2019-2024 ($)
Figure 14: Global Computational Medicine And Drug Discovery Software Market - By Geography
Figure 15: Global Computational Medicine And Drug Discovery Software Market Value & Volume, By Geography, 2019-2024 ($) 
Figure 16: Global Computational Medicine And Drug Discovery Software Market CAGR, By Geography, 2019-2024 (%)
Figure 17: North America Computational Medicine And Drug Discovery Software Market Value & Volume, 2019-2024 ($)
Figure 18: US Computational Medicine And Drug Discovery Software Market Value & Volume, 2019-2024 ($)
Figure 19: US GDP and Population, 2018-2019 ($)
Figure 20: US GDP – Composition of 2018, By Sector of Origin
Figure 21: US Export and Import Value & Volume, 2018-2019 ($)
Figure 22: Canada Computational Medicine And Drug Discovery Software Market Value & Volume, 2019-2024 ($)
Figure 23: Canada GDP and Population, 2018-2019 ($)
Figure 24: Canada GDP – Composition of 2018, By Sector of Origin
Figure 25: Canada Export and Import Value & Volume, 2018-2019 ($)
Figure 26: Mexico Computational Medicine And Drug Discovery Software Market Value & Volume, 2019-2024 ($)
Figure 27: Mexico GDP and Population, 2018-2019 ($)
Figure 28: Mexico GDP – Composition of 2018, By Sector of Origin
Figure 29: Mexico Export and Import Value & Volume, 2018-2019 ($)
Figure 30: South America Computational Medicine And Drug Discovery Software Market Value & Volume, 2019-2024 ($)
Figure 31: Brazil Computational Medicine And Drug Discovery Software Market Value & Volume, 2019-2024 ($)
Figure 32: Brazil GDP and Population, 2018-2019 ($)
Figure 33: Brazil GDP – Composition of 2018, By Sector of Origin
Figure 34: Brazil Export and Import Value & Volume, 2018-2019 ($)
Figure 35: Venezuela Computational Medicine And Drug Discovery Software Market Value & Volume, 2019-2024 ($)
Figure 36: Venezuela GDP and Population, 2018-2019 ($)
Figure 37: Venezuela GDP – Composition of 2018, By Sector of Origin
Figure 38: Venezuela Export and Import Value & Volume, 2018-2019 ($)
Figure 39: Argentina Computational Medicine And Drug Discovery Software Market Value & Volume, 2019-2024 ($)
Figure 40: Argentina GDP and Population, 2018-2019 ($)
Figure 41: Argentina GDP – Composition of 2018, By Sector of Origin
Figure 42: Argentina Export and Import Value & Volume, 2018-2019 ($)
Figure 43: Ecuador Computational Medicine And Drug Discovery Software Market Value & Volume, 2019-2024 ($)
Figure 44: Ecuador GDP and Population, 2018-2019 ($)
Figure 45: Ecuador GDP – Composition of 2018, By Sector of Origin
Figure 46: Ecuador Export and Import Value & Volume, 2018-2019 ($)
Figure 47: Peru Computational Medicine And Drug Discovery Software Market Value & Volume, 2019-2024 ($)
Figure 48: Peru GDP and Population, 2018-2019 ($)
Figure 49: Peru GDP – Composition of 2018, By Sector of Origin
Figure 50: Peru Export and Import Value & Volume, 2018-2019 ($)
Figure 51: Colombia Computational Medicine And Drug Discovery Software Market Value & Volume, 2019-2024 ($)
Figure 52: Colombia GDP and Population, 2018-2019 ($)
Figure 53: Colombia GDP – Composition of 2018, By Sector of Origin
Figure 54: Colombia Export and Import Value & Volume, 2018-2019 ($)
Figure 55: Costa Rica Computational Medicine And Drug Discovery Software Market Value & Volume, 2019-2024 ($)
Figure 56: Costa Rica GDP and Population, 2018-2019 ($)
Figure 57: Costa Rica GDP – Composition of 2018, By Sector of Origin
Figure 58: Costa Rica Export and Import Value & Volume, 2018-2019 ($)
Figure 59: Europe Computational Medicine And Drug Discovery Software Market Value & Volume, 2019-2024 ($)
Figure 60: U.K Computational Medicine And Drug Discovery Software Market Value & Volume, 2019-2024 ($)
Figure 61: U.K GDP and Population, 2018-2019 ($)
Figure 62: U.K GDP – Composition of 2018, By Sector of Origin
Figure 63: U.K Export and Import Value & Volume, 2018-2019 ($)
Figure 64: Germany Computational Medicine And Drug Discovery Software Market Value & Volume, 2019-2024 ($)
Figure 65: Germany GDP and Population, 2018-2019 ($)
Figure 66: Germany GDP – Composition of 2018, By Sector of Origin
Figure 67: Germany Export and Import Value & Volume, 2018-2019 ($)
Figure 68: Italy Computational Medicine And Drug Discovery Software Market Value & Volume, 2019-2024 ($)
Figure 69: Italy GDP and Population, 2018-2019 ($)
Figure 70: Italy GDP – Composition of 2018, By Sector of Origin
Figure 71: Italy Export and Import Value & Volume, 2018-2019 ($)
Figure 72: France Computational Medicine And Drug Discovery Software Market Value & Volume, 2019-2024 ($)
Figure 73: France GDP and Population, 2018-2019 ($)
Figure 74: France GDP – Composition of 2018, By Sector of Origin
Figure 75: France Export and Import Value & Volume, 2018-2019 ($)
Figure 76: Netherlands Computational Medicine And Drug Discovery Software Market Value & Volume, 2019-2024 ($)
Figure 77: Netherlands GDP and Population, 2018-2019 ($)
Figure 78: Netherlands GDP – Composition of 2018, By Sector of Origin
Figure 79: Netherlands Export and Import Value & Volume, 2018-2019 ($)
Figure 80: Belgium Computational Medicine And Drug Discovery Software Market Value & Volume, 2019-2024 ($)
Figure 81: Belgium GDP and Population, 2018-2019 ($)
Figure 82: Belgium GDP – Composition of 2018, By Sector of Origin
Figure 83: Belgium Export and Import Value & Volume, 2018-2019 ($)
Figure 84: Spain Computational Medicine And Drug Discovery Software Market Value & Volume, 2019-2024 ($)
Figure 85: Spain GDP and Population, 2018-2019 ($)
Figure 86: Spain GDP – Composition of 2018, By Sector of Origin
Figure 87: Spain Export and Import Value & Volume, 2018-2019 ($)
Figure 88: Denmark Computational Medicine And Drug Discovery Software Market Value & Volume, 2019-2024 ($)
Figure 89: Denmark GDP and Population, 2018-2019 ($)
Figure 90: Denmark GDP – Composition of 2018, By Sector of Origin
Figure 91: Denmark Export and Import Value & Volume, 2018-2019 ($)
Figure 92: APAC Computational Medicine And Drug Discovery Software Market Value & Volume, 2019-2024 ($)
Figure 93: China Computational Medicine And Drug Discovery Software Market Value & Volume, 2019-2024
Figure 94: China GDP and Population, 2018-2019 ($)
Figure 95: China GDP – Composition of 2018, By Sector of Origin
Figure 96: China Export and Import Value & Volume, 2018-2019 ($)Computational Medicine And Drug Discovery Software Market China Export and Import Value & Volume, 2018-2019 ($)
Figure 97: Australia Computational Medicine And Drug Discovery Software Market Value & Volume, 2019-2024 ($)
Figure 98: Australia GDP and Population, 2018-2019 ($)
Figure 99: Australia GDP – Composition of 2018, By Sector of Origin
Figure 100: Australia Export and Import Value & Volume, 2018-2019 ($)
Figure 101: South Korea Computational Medicine And Drug Discovery Software Market Value & Volume, 2019-2024 ($)
Figure 102: South Korea GDP and Population, 2018-2019 ($)
Figure 103: South Korea GDP – Composition of 2018, By Sector of Origin
Figure 104: South Korea Export and Import Value & Volume, 2018-2019 ($)
Figure 105: India Computational Medicine And Drug Discovery Software Market Value & Volume, 2019-2024 ($)
Figure 106: India GDP and Population, 2018-2019 ($)
Figure 107: India GDP – Composition of 2018, By Sector of Origin
Figure 108: India Export and Import Value & Volume, 2018-2019 ($)
Figure 109: Taiwan Computational Medicine And Drug Discovery Software Market Value & Volume, 2019-2024 ($)
Figure 110: Taiwan GDP and Population, 2018-2019 ($)
Figure 111: Taiwan GDP – Composition of 2018, By Sector of Origin
Figure 112: Taiwan Export and Import Value & Volume, 2018-2019 ($)
Figure 113: Malaysia Computational Medicine And Drug Discovery Software Market Value & Volume, 2019-2024 ($)
Figure 114: Malaysia GDP and Population, 2018-2019 ($)
Figure 115: Malaysia GDP – Composition of 2018, By Sector of Origin
Figure 116: Malaysia Export and Import Value & Volume, 2018-2019 ($)
Figure 117: Hong Kong Computational Medicine And Drug Discovery Software Market Value & Volume, 2019-2024 ($)
Figure 118: Hong Kong GDP and Population, 2018-2019 ($)
Figure 119: Hong Kong GDP – Composition of 2018, By Sector of Origin
Figure 120: Hong Kong Export and Import Value & Volume, 2018-2019 ($)
Figure 121: Middle East & Africa Computational Medicine And Drug Discovery Software Market Middle East & Africa 3D Printing Market Value & Volume, 2019-2024 ($)
Figure 122: Russia Computational Medicine And Drug Discovery Software Market Value & Volume, 2019-2024 ($)
Figure 123: Russia GDP and Population, 2018-2019 ($)
Figure 124: Russia GDP – Composition of 2018, By Sector of Origin
Figure 125: Russia Export and Import Value & Volume, 2018-2019 ($)
Figure 126: Israel Computational Medicine And Drug Discovery Software Market Value & Volume, 2019-2024 ($)
Figure 127: Israel GDP and Population, 2018-2019 ($)
Figure 128: Israel GDP – Composition of 2018, By Sector of Origin
Figure 129: Israel Export and Import Value & Volume, 2018-2019 ($)
Figure 130: Entropy Share, By Strategies, 2018-2019* (%)Computational Medicine And Drug Discovery Software Market
Figure 131: Developments, 2018-2019*Computational Medicine And Drug Discovery Software Market
Figure 132: Company 1 Computational Medicine And Drug Discovery Software Market Net Revenue, By Years, 2018-2019* ($)
Figure 133: Company 1 Computational Medicine And Drug Discovery Software Market Net Revenue Share, By Business segments, 2018 (%)
Figure 134: Company 1 Computational Medicine And Drug Discovery Software Market Net Sales Share, By Geography, 2018 (%)
Figure 135: Company 2 Computational Medicine And Drug Discovery Software Market Net Revenue, By Years, 2018-2019* ($)
Figure 136: Company 2 Computational Medicine And Drug Discovery Software Market Net Revenue Share, By Business segments, 2018 (%)
Figure 137: Company 2 Computational Medicine And Drug Discovery Software Market Net Sales Share, By Geography, 2018 (%)
Figure 138: Company 3Computational Medicine And Drug Discovery Software Market Net Revenue, By Years, 2018-2019* ($)
Figure 139: Company 3Computational Medicine And Drug Discovery Software Market Net Revenue Share, By Business segments, 2018 (%)
Figure 140: Company 3Computational Medicine And Drug Discovery Software Market Net Sales Share, By Geography, 2018 (%)
Figure 141: Company 4 Computational Medicine And Drug Discovery Software Market Net Revenue, By Years, 2018-2019* ($)
Figure 142: Company 4 Computational Medicine And Drug Discovery Software Market Net Revenue Share, By Business segments, 2018 (%)
Figure 143: Company 4 Computational Medicine And Drug Discovery Software Market Net Sales Share, By Geography, 2018 (%)
Figure 144: Company 5 Computational Medicine And Drug Discovery Software Market Net Revenue, By Years, 2018-2019* ($)
Figure 145: Company 5 Computational Medicine And Drug Discovery Software Market Net Revenue Share, By Business segments, 2018 (%)
Figure 146: Company 5 Computational Medicine And Drug Discovery Software Market Net Sales Share, By Geography, 2018 (%)
Figure 147: Company 6 Computational Medicine And Drug Discovery Software Market Net Revenue, By Years, 2018-2019* ($)
Figure 148: Company 6 Computational Medicine And Drug Discovery Software Market Net Revenue Share, By Business segments, 2018 (%)
Figure 149: Company 6 Computational Medicine And Drug Discovery Software Market Net Sales Share, By Geography, 2018 (%)
Figure 150: Company 7 Computational Medicine And Drug Discovery Software Market Net Revenue, By Years, 2018-2019* ($)
Figure 151: Company 7 Computational Medicine And Drug Discovery Software Market Net Revenue Share, By Business segments, 2018 (%)
Figure 152: Company 7 Computational Medicine And Drug Discovery Software Market Net Sales Share, By Geography, 2018 (%)
Figure 153: Company 8 Computational Medicine And Drug Discovery Software Market Net Revenue, By Years, 2018-2019* ($)
Figure 154: Company 8 Computational Medicine And Drug Discovery Software Market Net Revenue Share, By Business segments, 2018 (%)
Figure 155: Company 8 Computational Medicine And Drug Discovery Software Market Net Sales Share, By Geography, 2018 (%)
Figure 156: Company 9 Computational Medicine And Drug Discovery Software Market Net Revenue, By Years, 2018-2019* ($)
Figure 157: Company 9 Computational Medicine And Drug Discovery Software Market Net Revenue Share, By Business segments, 2018 (%)
Figure 158: Company 9 Computational Medicine And Drug Discovery Software Market Net Sales Share, By Geography, 2018 (%)
Figure 159: Company 10 Computational Medicine And Drug Discovery Software Market Net Revenue, By Years, 2018-2019* ($)
Figure 160: Company 10 Computational Medicine And Drug Discovery Software Market Net Revenue Share, By Business segments, 2018 (%)
Figure 161: Company 10 Computational Medicine And Drug Discovery Software Market Net Sales Share, By Geography, 2018 (%)
Figure 162: Company 11 Computational Medicine And Drug Discovery Software Market Net Revenue, By Years, 2018-2019* ($)
Figure 163: Company 11 Computational Medicine And Drug Discovery Software Market Net Revenue Share, By Business segments, 2018 (%)
Figure 164: Company 11 Computational Medicine And Drug Discovery Software Market Net Sales Share, By Geography, 2018 (%)
Figure 165: Company 12 Computational Medicine And Drug Discovery Software Market Net Revenue, By Years, 2018-2019* ($)
Figure 166: Company 12 Computational Medicine And Drug Discovery Software Market Net Revenue Share, By Business segments, 2018 (%)
Figure 167: Company 12 Computational Medicine And Drug Discovery Software Market Net Sales Share, By Geography, 2018 (%)
Figure 168: Company 13Computational Medicine And Drug Discovery Software Market Net Revenue, By Years, 2018-2019* ($)
Figure 169: Company 13Computational Medicine And Drug Discovery Software Market Net Revenue Share, By Business segments, 2018 (%)
Figure 170: Company 13Computational Medicine And Drug Discovery Software Market Net Sales Share, By Geography, 2018 (%)
Figure 171: Company 14 Computational Medicine And Drug Discovery Software Market Net Revenue, By Years, 2018-2019* ($)
Figure 172: Company 14 Computational Medicine And Drug Discovery Software Market Net Revenue Share, By Business segments, 2018 (%)
Figure 173: Company 14 Computational Medicine And Drug Discovery Software Market Net Sales Share, By Geography, 2018 (%)
Figure 174: Company 15 Computational Medicine And Drug Discovery Software Market Net Revenue, By Years, 2018-2019* ($)
Figure 175: Company 15 Computational Medicine And Drug Discovery Software Market Net Revenue Share, By Business segments, 2018 (%)
Figure 176: Company 15 Computational Medicine And Drug Discovery Software Market Net Sales Share, By Geography, 2018 (%)